News
Pentax Medical Launches Industry's Highest Resolution HD+ Imaging Technology for Flexible Endoscopy
May 15, 2013 12:12 pm | by PENTAX Medical Company | CommentsPENTAX Medical Company, a healthcare industry leader in endoscopic imaging, announces the U.S. launch of the EPK-i®5010 Video Processor with PENTAX i-SCAN™, the industry's highest* resolution HD+ imaging technology for flexible endoscopy.
Body Fat Hardens Arteries After Middle Age
May 15, 2013 11:32 am | by Sam Wong, Imperial College London | CommentsHaving too much body fat makes arteries become stiff after middle age, a new study has revealed. In young people, blood vessels appear to be able to compensate for the effects of obesity. But after middle age, this adaptability is lost, and arteries become progressively stiffer as body fat rises – potentially increasing the risk of dying from cardiovascular disease.
New Blood Test Finds Allergies Before Implant Surgery
May 15, 2013 11:19 am | by National Jewish Health | CommentsA growing number of patients learn of allergies to new hips and knees only after surgery is done. Imagine what Paula Spurlock must have been going through. Shortly after having a hip replaced in 2011, the trouble started. "I had horrible itching, really bad migraines and intense pain throughout my body," she said. "I couldn't take it. Every single thing in me itched."
ACell MatriStem Technology Ranks Highest in Constructive Remodeling
May 15, 2013 11:01 am | by The Associated Press | CommentsACell, Inc., a leading developer of next-generation regenerative medicine products, announced today that its MatriStem medical devices demonstrate the highest constructive remodeling response in a recent study comparing 14 extracellular matrices (ECM) designed to aid in surgical procedures. ...
Engineered Biomaterial Could Improve Success of Medical Implants
May 15, 2013 10:22 am | by Michelle Ma, University of Washington | CommentsIt’s a familiar scenario – a patient receives a medical implant and days later, the body attacks the artificial valve or device, causing complications to an already compromised system. Expensive, state-of-the-art medical devices and surgeries often are thwarted by the body’s natural response to attack something in the tissue that appears foreign.
MiE's PET SCINTRON Receives FDA Approval
May 15, 2013 9:51 am | by Bio-Medicine.Org | CommentsHOUSTON , May 15, 2013 /PRNewswire-iReach/ -- Medical Imaging Electronics (MiE) and Nuclear Imaging Services (NIS) are pleased to announce that the ECAT Scintron has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). MiE along with NIS will showcase this product at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting in Vancouver, BC , Canada Ju...
Cardica Completes Enrollment In European Clinical Trial For Surgical Cutting And Stapling Device
May 15, 2013 8:00 am | by The Associated Press | CommentsCardica, Inc. (Nasdaq: CRDC) today announced it has completed enrollment in the European clinical study for its MicroCutter XCHANGET 30, a cartridge-based cutting/stapling device with a 5-millimeter shaft diameter and cross-sectional area more than six times smaller than standard...
ApoCell Announces Delivery of First Prototypes of ApoStreamT Circulating Tumor Cell (CTC) Isolation Technology to National Cancer Institute
May 15, 2013 8:00 am | by The Associated Press | CommentsApoCell, Inc. announced that the first prototypes of its ApoStreamT circulating tumor cell (CTC) isolation system have been delivered to select investigator sites including SAIC-Frederick Inc. (SAIC-F) in support of the National Cancer Institute (NCI). The delivery is part of a $2.9 million ...
IPG Launches IPG PathFinder 360™, Transforming Healthcare through Cost Transparency
May 15, 2013 8:00 am | by The Associated Press | CommentsATLANTA--(BUSINESS WIRE)--May 15, 2013--IPG, the industry leading provider of Device Benefit Management™ (DBM) solutions, announced today the launch of a solution that will drastically transform healthcare through cost transparency. Built on the intelligence and expertise from IPG’s proven DBM...
Elixir Medical Receives CE Mark Approval for the Fully Bioresorbable DESolve® Novolimus Eluting Coronary Scaffold System
May 15, 2013 7:00 am | by The Associated Press | CommentsSUNNYVALE, Calif.--(BUSINESS WIRE)--May 15, 2013--Elixir Medical Corporation, a developer of product platforms that combine state-of-the-art medical devices with advanced pharmaceuticals, announced that it has received CE (Conformité Européenne) Mark approval for its DESolve ® Novolimus Eluting...
Southern Denmark Tackles Heart Disease with IBM Big Data Analytics Program
May 15, 2013 5:35 am | by IBM | CommentsIBM announced today that the Region of Southern Denmark is launching a new program to provide comprehensive insight to improve the quality and comprehensiveness of care for patients with chronic illness. The goal of the program is to facilitate real-time communication among patients, physicians, pharmacists, mental health professionals and specialists so all parties have insight into patient care plans.
Emphasis on X-Ray Quality Spurs Adoption of Computed and Digital Radiography in Europe, Finds Frost & Sullivan
May 15, 2013 4:07 am | by Bio-Medicine.Org | CommentsLONDON , May 15, 2013 /- The need to improve the efficiency and quality of X-ray examinations will drive healthcare facilities across Europe to install computed radiography (CR) and digital radiography (DR) systems. The emergence of retrofit systems based on flat panel technology has popularised DR systems, and will sustain investments in the European computed and digita...
Mitsubishi Electric Begins Testing New Proton Therapy Technology
May 14, 2013 9:30 pm | by The Associated Press | CommentsTOKYO--(BUSINESS WIRE)--May 14, 2013--Mitsubishi Electric Corporation (TOKYO:6503) announced today that it has completed the construction of a new proton therapy system for cancer treatment at its Energy Systems Center in Kobe, Hyogo Prefecture. The company has started testing of the new...
Using Clay to Grow Bone
May 14, 2013 3:10 pm | by Brigham and Women's Hospital | CommentsIn new research published online May 13, 2013 in Advanced Materials, researchers from Brigham and Women's Hospital (BWH) are the first to report that synthetic silicate nanoplatelets (also known as layered clay) can induce stem cells to become bone cells without the need of additional bone-inducing factors.
Pitt Chemists Demonstrate Nanoscale Alloys So Bright They Could Have Potential Medical Applications
May 14, 2013 3:05 pm | by University of Pittsburgh | CommentsAlloys like bronze and steel have been transformational for centuries, yielding top-of-the-line machines necessary for industry. As scientists move toward nanotechnology, however, the focus has shifted toward creating alloys at the nanometer scale—producing materials with properties unlike their predecessors.
